Position in ANNX
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$2,308,506
-$914,524 QoQ
Shares Held
416,698
-35.1% QoQ
Ownership
0.209%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ANNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC holds $137,627,958 across 40 Biotechnology names. ANNX ranks #22 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
26,967 | $12,041,844 | |
| 2 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
184,304 | $11,555,860 | |
| 3 | KRYS |
Krystal Biotech, Inc.
|
35,859 | $9,263,096 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
10,702 | $8,268,793 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
41,936 | $7,088,022 | |
| 6 | XENE |
Xenon Pharmaceuticals Inc.
|
115,594 | $6,721,791 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
12,069 | $6,317,759 | |
| 8 | INSM |
INSMED Inc
|
36,881 | $6,030,781 |
All Filings in ANNX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,308,506 | 416,698 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $3,223,030 | 642,038 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $3,254,142 | 1,066,932 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $2,589,506 | 1,078,961 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $1,989,218 | 1,030,683 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $5,282,258 | 1,029,680 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $3,902,783 | 659,254 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $3,133,907 | 639,573 | Shares | Sole | 2024-08-09 | |
| No filing history on record for this holder in this stock. | ||||||